The growth of the cannabis industry is contingent on access to capital. Sharp strives to develop and deliver the optimal capital structure to support its clients' goals and objectives.

Until the passage of federal legislation such as the MORE act or SAFE banking act, debt and equity capital available to operators in the cannabis sector from traditional institutional sources (e.g., commercial banks, private equity) will be scarce.

That said, Sharp maintains a database and active dialogue with over a thousand alternative debt funds, hedge funds, family offices and other sources of capital that do have an interest and willingness to invest in the sector.  

Moreover, Sharp principals have extensive prior experience developing, financing and managing commercial real estate. Given the massive need for capital to finance cultivation, manufacturing and retail real estate in the sector, Sharp maintains deep relationships with a myriad of developers and financiers to assist our clients in funding their growth.  

Often times, the perceived lack of fixed income capital has led operators to utilize more expensive equity or equity-like securities to finance their operations.  Our team is able to quickly asses our clients' most cost-effective capital structure and manage a placement process that ensures the best pricing and terms available in the marketplace.

We specialize in the following types of financings:

  • Common / Preferred Equity
  • Secured Senior Debt
  • Junior / Convertible Debt
  • Sale-Leasebacks / Development Capital